Fifth Lane Capital, LP F Star Therapeutics, Inc. Transaction History
Fifth Lane Capital, LP
- $37.3 Million
- Q3 2024
A detailed history of Fifth Lane Capital, LP transactions in F Star Therapeutics, Inc. stock. As of the latest transaction made, Fifth Lane Capital, LP holds 12,800 shares of FSTX stock, worth $0. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,800Holding current value
$0% of portfolio
0.07%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding FSTX
# of Institutions
3Shares Held
44.7KCall Options Held
0Put Options Held
0About F-star Therapeutics, Inc.
- Ticker FSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,584,700
- Description
- F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...